Hippurate-131I for injection

Specyfikacja
Czystość radionuklidowa: 

≥ 99.9%

Czystość radiochemiczna: 

≥ 96%

Kalibracja: 

7 days

Okres ważności: 

Hippurate-131I for injection expires 21 days from manufacturing date.

Warunki przechowywania: 

Store in refrigerator (2OC - 8OC).
During transportation (not longer than 7 days after production date) up to 25OC.

Postać farmaceutyczna: 

Solution for injection.

Skład jakościowy i ilościowy substancji czynnych: 

Sodium 2-[131I]iodohippurate 3.7 - 74 MBq/ml

Wykaz substancji pomocniczych: 

benzyl alcohol
sodium chloride
water for injection

Rodzaj i zawartość opakowania: 

10 ml glass vial sealed with a rubber stopper and an aluminum crimp cap, placed in a lead shielding container. The vial contains a volume of the solution corresponding to the activity determined  on the calibration day.

Wskazania do stosowania: 

Hippurate-131I is a radiopharmaceutical used in diagnostics of kidneys dysfunction and urinary tract obstructions (dynamic renal scintigraphy, renoscintigraphy).
Renal scintigraphy utilizing this radiopharmaceutical allows the evaluation of:
• kidney blood flow resolution (effective renal plasma flow – ERPF),
• renal tubular  function,
• urine outflow from the pyelocalyceal system,
• vesico-ureteral reflux (examination during miction),
• renal function impairment in transplanted kidney
and can be used in the diagnostics of renovascular hypertension (particularly in the captopril enhanced renal scintigraphy).
The preparation accumulates in the kidneys where it concentrates and is later excreted.

Załączniki: 
Pliki




	
	
  

Nasza siedziba

Produkty

Certyfikaty